Allurion Technologies, Inc. Warrants, each whole warrant exerci — Cash Flow (NYSE:ALUR-WT) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 64 M42.3 M 36.9 M Cash from investing activities 1.61 M611 K — Cash from financing activities 95.99 M20.21 M 14.32 M Free cash flow 62.39 M41.69 M 36.9 M

Nachrichten

Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?

What's Going On With Allurion Stock On Wednesday? - Allurion Technologies (NYSE:ALUR)

Allurion-Aktie: Hochstufung auf „Buy“ nach FDA-Zulassung

Allurion Technologies stock rating upgraded on FDA approval

FDA-Zulassung für Magenballon: Allurion-Aktie schießt um 40 % in die Höhe

FDA approves Allurion gastric balloon for obesity treatment

Allurion stock surges 40% on U.S. FDA approval

Tracking Saudi Sovereign Wealth Fund’s 13F Portfolio – Q3 2025 Update

Allurion Technologies (ALUR) director sells $4.9k in shares

Allurion reports 23% weight loss combining balloon with low-dose GLP-1

Allurion Smart Capsule shows 20% weight reduction in new study

Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion